CD&R, Merck GHI, and McKesson Ventures Investment in M2GEN

Todd Finger ,Scott Abramowitz,Allie Alperovich,Megan Baca ,Michael Beauvais,Megan Bisk,Albert Cacozza,Adam Greenwood,David Peloquin,Carolyn Vardi,McDermott Will & Emery,Ropes & Gray,Clayton Dubilier & Rice,Merck Global Health Innovation Fund, LLC,

Ropes & Gray acted as legal advisor to Clayton, Dubilier & Rice (“CD&R”) funds in the transaction. McDermott Will & Emery represented Merck Global Health Innovation Fund (Merck GHI).

M2GEN announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership with its existing shareholders. The financial terms of the transaction, which closed today, were not disclosed.

Existing shareholders Moffitt Cancer Center, Hearst Healthcare, and The Ohio State University Foundation continue to hold a significant minority interest in M2GEN. 

Founded in 2006, M2GEN is a leading oncology data and informatics platform focused on transforming cancer care.

Clayton, Dubilier & Rice, a private investment firm with offices in New York and London, has managed the investment of more than $30 billion in 98 companies with an aggregate transaction value of more than $150 billion. 

Green Shoots Consulting, LLC served as advisor to Merck GHI.

The Ropes & Gray team representing CD&R was led by private equity partners Carolyn Vardi (New York; Picture) and Scott Abramowitz (New York), and included health care partner David Peloquin (Boston), life sciences regulatory & compliance partner Albert Cacozza (Washington D.C.), IP transactions partner Megan Baca (Silicon Valley), mergers & acquisitions partner Michael Beauvais (Boston), employment, executive compensation & employment partners Allie Alperovich (New York) and Megan Bisk (Boston), and tax partner Adam Greenwood (New York).

McDermott Will & Emery represented Merck Global Health Innovation Fund (Merck GHI) with a team led by Todd Finger.

Involved fees earner: Todd Finger – McDermott Will & Emery; Scott Abramowitz – Ropes & Gray; Allie Alperovich – Ropes & Gray; Megan Baca – Ropes & Gray; Michael Beauvais – Ropes & Gray; Megan Bisk – Ropes & Gray; Albert Cacozza – Ropes & Gray; Adam Greenwood – Ropes & Gray; David Peloquin – Ropes & Gray; Carolyn Vardi – Ropes & Gray;

Law Firms: McDermott Will & Emery; Ropes & Gray;

Clients: Clayton Dubilier & Rice; Merck Global Health Innovation Fund, LLC;

Print Friendly, PDF & Email